DocMorris Ltd.

  • Market Cap: N/A
  • Industry: Retailing
  • ISIN: CH0042615283
CHF
5.90
0.1 (1.72%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

608.9 k

Shareholding (Dec 2023)

FII

0.93%

Held by 2 FIIs

DII

99.07%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0%

  • Poor long term growth as Operating profit has grown by an annual rate 4.34% of over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
2

Flat results in Dec 24

3

Risky -

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Retailing

stock-summary
Market cap

CHF 288 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.57

stock-summary
Return on Equity

-20.25%

stock-summary
Price to Book

0.60

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.83%
0%
-5.83%
6 Months
-13.04%
0%
-13.04%
1 Year
-54.27%
0%
-54.27%
2 Years
-82.26%
0%
-82.26%
3 Years
-56.74%
0%
-56.74%
4 Years
-96.24%
0%
-96.24%
5 Years
-95.63%
0%
-95.63%

DocMorris Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-7.19%
EBIT Growth (5y)
4.34%
EBIT to Interest (avg)
-5.22
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.71
Sales to Capital Employed (avg)
1.60
Tax Ratio
5.37%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.66
EV to EBIT
-4.18
EV to EBITDA
-8.56
EV to Capital Employed
0.69
EV to Sales
0.37
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-16.61%
ROE (Latest)
-20.25%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
Bearish
OBV
Mildly Bullish
Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2023stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 2 Foreign Institutions (0.93%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by DocMorris Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 4.90% vs 4.14% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 17.26% vs 31.27% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,017.00",
          "val2": "969.50",
          "chgp": "4.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-45.90",
          "val2": "-32.40",
          "chgp": "-41.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "20.00",
          "val2": "19.90",
          "chgp": "0.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "-2.00",
          "chgp": "105.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-97.30",
          "val2": "-117.60",
          "chgp": "17.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-90.00%",
          "val2": "-78.20%",
          "chgp": "-1.18%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,017.00
969.50
4.90%
Operating Profit (PBDIT) excl Other Income
-45.90
-32.40
-41.67%
Interest
20.00
19.90
0.50%
Exceptional Items
0.10
-2.00
105.00%
Consolidate Net Profit
-97.30
-117.60
17.26%
Operating Profit Margin (Excl OI)
-90.00%
-78.20%
-1.18%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 4.90% vs 4.14% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 17.26% vs 31.27% in Dec 2023

stock-summaryCompany CV
About DocMorris Ltd. stock-summary
stock-summary
DocMorris Ltd.
Retailing
Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.
Company Coordinates stock-summary
Company Details
Walzmuehlestrasse 60 , FRAUENFELD None : 8500
stock-summary
Tel: 41 52 724002041 58 7240064
stock-summary
Registrar Details